| For: | Liu L, Behera TR, Wang QJ, Shen QQ. Advances in mesenchymal stem cell therapy for lupus nephritis. World J Stem Cells 2025; 17(8): 104930 [PMID: 40951714 DOI: 10.4252/wjsc.v17.i8.104930] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v17/i8/104930.htm |
| Number | Citing Articles |
| 1 |
Zahra Jafari, Zahra Hamzehpour, Maryam Faghihi, Reza Arab Derazi, Masoud Hassanzadeh Makoui, Reza Hassanzadeh Makoui, Shiva Fekri, Negar Ansari, Seyyed Shamsadin Athari. Modified mesenchymal stem cells as an innovative therapeutic approach in systemic lupus erythematosus: A comprehensive review. Modern Rheumatology 2026; 36(2) doi: 10.1093/mr/roaf112
|
| 2 |
Guanhua Zhang, Jie Guo, Xue Wu, Xin Li, Hang Liu, Yiming Ji, Ya Su, Ying Zhang, Yang Zhang, Shichen Lin, Shaoyu Duan. PTEN-knockdown modified T2DM ADSCs-derived extracellular vesicles promote T2DM implant osseointegration by enhancing the osteogenic differentiation of bone marrow mesenchymal stem cells. Pathology - Research and Practice 2026; 283 doi: 10.1016/j.prp.2026.156514
|